YORBA LINDA, CA (PRWEB)
September 01, 2022
Labroots, the leading scientific social networking website offering premier virtual events and interactive webinars, is thrilled to announce its Virtual Microbiology Week free online event. From September 6-8, researchers, top scientists, healthcare professionals, microbiologists, infectious disease specialists and clinicians from around the world will gather under one virtual roof to hear from eminent speakers discuss their recent contributions and the latest discoveries in the field.
The avant-garde 3 days agenda will feature over 35 thought leaders from industry and academic institutions providing dynamic insights, and including stellar keynotes and panel presentations you won’t want to miss!
Highlights of Microbiology Virtual Week 2022 include five renowned speakers headlining the virtual stage:
- Josef Neu, MD, Professor, Department of Pediatrics, Division of Neonatology, University of Florida: AI and multi-omics in the perinatal period.
- Daniel Griffin, MD, PhD, Chief, Division of Infectious Diseases – ProHEALTH, an OPTUM Company, Clinical Instructor of Medicine – Columbia University College of Physicians and Surgeons, Department of Medicine-Division of Infectious Diseases: The Importance of Timing: Managing COVID- 19 (with live Q&A).
- Kate L. Jeffrey, PhD, Executive Director, Moderna Therapeutics: Functional Consequences of Human Enteric Virus (with live Q&A).
- Francisco Veas, PhD, Research Director and Professor, University of Montpellier: Ultrasensitive Detection of Respiratory Viruses During Apoh-Viral Enrichment from Non-Invasive, Self-Collectable Mouthwash Sampling (with Q&A live).
- Jonathan Abraham, MD, PhD, assistant professor of microbiology, Harvard Medical School, associate physician of infectious diseases, Brigham & Women’s Hospital: Lipoprotein receptors are evolutionarily conserved cellular receptors for divergent alphaviruses (with questions and answers in direct).
Dr. Daniel Griffin, Chief, Division of Infectious Diseases – ProHEALTH, an OPTUM Company, Clinical Instructor of Medicine – Columbia University College of Physicians and Surgeons, Department of Medicine-Division of Infectious Diseases, said, “The COVID- 19 reminded many and for the first time informed others of how devastating a microscopic life form can be to our way of life. Despite advanced technologies and numerous preparations, this virus has killed millions of people and transformed our society. The triumphs and ultimately our ability to move forward are testament to the power of science in the form of vaccines and therapies. As we continue to make progress, the biggest challenge remains, as always: educating physicians and patients on how best to use these powerful tools.
Dr. Kate L. Jeffrey, Executive Director of Moderna Therapeutics, commented: “Although the microbiome is established as an important regulator of health and disease, the role of prokaryotic and eukaryotic viruses that inhabit asymptomatic humans (collectively, the virome) is less defined. Sequencing efforts have shown clear virome disruptions in a range of diseases, including inflammatory bowel disease (IBD). triggers inflammation and causes disease Our work provides a functional missing link to which our collective virome – which is established at birth, shaped throughout life and includes a large number of known viruses and abundant “dark matter” that we cannot yet identify – is a significant contributor to human health, but when disrupted causes inflammation in IBD and possibly many other diseases.
Dr Francisco Veas, Professor, Research Director and Professor in the Departments of Microbiology and Medicine at the University of Montpellier at the Icahn School of Medicine at Mount Sinai said: “The changing planetary situation is experiencing multiple complications. rapid and severe impacting all aspects of life. These changes include, severe climate change, very significant losses of biodiversity (respectively 70%, 80% 50% of vertebrates, insects and birds have disappeared in less than 40 years, and all the rest are in the process of accelerated extinction) , and the disappearance of natural habitats (wetlands, mangroves, glaciers, polar ice caps, rivers, lakes, etc.), forests. All these aspects are correlated with the increase in an uncontrolled human demography (8 billion humans this year against 1.5 billion in 1900) of consumers (new synonym of human), mainly since the middle of the 20th century due to the use of antibiotics, mass vaccination and new therapies. This has created a paradox which implies that medicine, while providing a longer and healthier life, indirectly contributes to the acceleration of the destruction of our habitat. These environmental changes induce higher concentrations of zoonotic hosts of pathogens outside of their large historical endemic areas, not visited by humans, where they were previously “diluted” (e.g. SARS-CoV-2, Monkeypox virus , Lyme disease, etc. ). To provide high quality public health to protect populations from (re)emerging diseases in this context, two main related mandatory actions should be considered within a One Health approach: (i) new creative measures to urgently reverse the environmental problems and demographic tragedies mentioned above, but also (ii) carry out classic public health countermeasures, by developing (preparing) more effective methods allowing better surveillance with ultra-sensitive detection and ultra-fast circulating pathogens to adopt the first optimized therapeutics or vaccine for individual and epidemic management/containment. The Labroots platform is a great way to not only share these new integrative ways of thinking “health and health of the planet”, but also to offer complementary technologies that could address unmet medical needs. »
The scientific program explores informative sessions such as host immune response to bacterial pathogens, innate immunity, viral replication, antimicrobial resistance and new antimicrobial strategies, point-of-care diagnostics – lessons learned from COVD-19 testing, virus genomics, emerging and re-emerging respiratory diseases. viruses, the microbiome in women’s health, the microbiome in cancer risk and treatment, viromes and bacteriophages, genomic epidemiology and pandemic preparedness, and much more.
“Labroots created this virtual event 10 years ago to bring attention to the disciplines of microbiology by bringing together the scientific community to learn about cutting-edge discoveries and innovative technologies,” added Greg Cruikshank, CEO of Labroots. “Continuing our commitment, Virtual Microbiology Week has been the must-attend conference, providing an unparalleled platform for leading experts to exchange ideas in the fields of immunology, microbiology and cancer research during this educational forum.”
Produced on Labroots’ robust platform while connecting to all desktop and mobile devices, the online environment includes a lobby with leaderboards and gamification, an auditorium featuring live video webcasts offering discussions live to attendees during scheduled presentations, an interactive display room with a poster contest and live chat conversations), an exhibition hall (interact with sponsors and learn about the latest range of products and technologies ) and a networking lounge to connect with your colleagues. By attending this event, you can earn 1 continuing education credit per presentation for a maximum of 50 credits.
To register for the event, Click here. Participants can use the official #LRmicro hashtag to follow the conversation and connect with other members of the global microbiology community. Follow @Microbiology_LR on Twitter and @Microbiology.LR on Facebook to connect with our expert microbiology editors and stay up to date with the latest trends in microbiology. And now you can also join our microbiology interest group on LinkedIn to communicate with us!
Labroots is the leading science social networking website and leading source for science news and leading virtual events and educational webinars and more. Advancing science through content sharing capabilities, Labroots is a powerful advocate for amplifying global networks and communities. Founded in 2008, Labroots focuses on digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay at the top of their field by earning continuing education credits on a wide range of topics through their participation in webinars and virtual events.